Boston Scientific Corporation (BSX)

NYSE: BSX · Real-Time Price · USD

43.34

-0.21 (-0.48%)

At close: Sep 18, 2026, 4:00 PM EDT

43.53

+0.19 (0.44%)

After-hours: Sep 18, 2026, 7:58 PM EDT

Boston Scientific Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	62,810	141,351	131,642	84,691	66,273	60,534
Market Cap Growth	-56.97%	7.38%	55.44%	27.79%	9.48%	17.59%
Enterprise Value	74,895	152,357	140,646	93,281	74,869	68,049
Last Close Price	43.34	95.35	89.32	57.81	46.27	42.48

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	17.56	48.78	71.04	53.94	103.23	61.46
Forward PE	13.25	28.71	33.08	26.76	24.51	23.73
PS Ratio	2.99	7.04	7.86	5.95	5.23	5.09
PB Ratio	2.52	5.78	5.98	4.34	3.77	3.64
P/FCF Ratio	17.33	38.64	49.77	47.26	70.65	46.00
P/OCF Ratio	13.87	31.18	38.32	33.84	43.43	32.37
PEG Ratio	1.04	1.65	2.42	2.19	2.30	1.64

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	3.57	7.59	8.40	6.55	5.90	5.72
EV/EBITDA Ratio	13.11	28.54	32.93	25.82	23.63	23.33
EV/EBIT Ratio	17.43	38.37	46.85	38.59	36.83	37.31
EV/FCF Ratio	20.66	41.65	53.17	52.05	79.82	51.71

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.50	0.49	0.51	0.49	0.53	0.57
Debt / EBITDA Ratio	2.21	2.19	2.57	2.58	2.87	3.17
Debt / FCF Ratio	3.48	3.27	4.25	5.34	9.96	7.24
Net Debt / Equity Ratio	0.48	0.41	0.49	0.45	0.48	0.46
Net Debt / EBITDA Ratio	2.12	1.87	2.53	2.41	2.66	2.61
Net Debt / FCF Ratio	3.33	2.74	4.09	4.86	8.97	5.78
Asset Turnover	0.48	0.48	0.45	0.42	0.39	0.38
Inventory Turnover	2.12	2.18	2.00	2.02	2.30	2.54
Quick Ratio	0.56	0.90	0.46	0.63	0.76	0.87
Current Ratio	1.24	1.62	1.08	1.32	1.52	1.48
Return on Equity (ROE)	15.34%	12.45%	8.88%	8.58%	4.08%	6.52%
Return on Assets (ROA)	6.19%	5.98%	5.04%	4.47%	3.93%	3.62%
Return on Invested Capital (ROIC)	11.20%	10.08%	7.95%	7.15%	4.95%	7.43%
Return on Capital Employed (ROCE)	11.10%	10.40%	9.10%	8.00%	7.10%	6.50%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	5.85%	2.05%	1.41%	1.88%	1.05%	1.72%
FCF Yield	5.77%	2.59%	2.01%	2.12%	1.42%	2.17%
Payout Ratio	-	-	-	-	7.88%	5.28%
Buyback Yield / Dilution	0.05%	-0.58%	-1.53%	-1.65%	-0.41%	-1.21%

SEC Filings: 10-K · 10-Q